晚发型多系统萎缩与早发型多系统萎缩不同。 - Suppr

Suppr

超能文献

Late-onset MSA differs from younger-onset MSA.

作者信息

Jellinger Kurt A

机构信息

Institute of Clinical Neurobiology, Vienna, Austria

出版信息

J Neurol Neurosurg Psychiatry. 2023 Jul;94(7):583. doi: 10.1136/jnnp-2022-328793. Epub 2022 Jun 2.

DOI:10.1136/jnnp-2022-328793

PMID:35654583

Abstract

摘要

相似文献

Late-onset MSA differs from younger-onset MSA.

J Neurol Neurosurg Psychiatry. 2023 Jul;94(7):583. doi: 10.1136/jnnp-2022-328793. Epub 2022 Jun 2.

Alpha-synuclein in erythrocyte membrane of patients with multiple system atrophy: A pilot study.

Parkinsonism Relat Disord. 2019 Mar;60:105-110. doi: 10.1016/j.parkreldis.2018.09.012. Epub 2018 Sep 11.

Definite familial multiple system atrophy with unknown genetics.

Neuropathology. 2014 Jun;34(3):309-13. doi: 10.1111/neup.12092. Epub 2014 Jan 7.

Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy.

J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):175-184. doi: 10.1136/jnnp-2017-315813. Epub 2017 Aug 31.

Distinct Autoimmune Anti-α-Synuclein Antibody Patterns in Multiple System Atrophy and Parkinson's Disease.

Front Immunol. 2019 Sep 24;10:2253. doi: 10.3389/fimmu.2019.02253. eCollection 2019.

Alpha-synuclein seeding shows a wide heterogeneity in multiple system atrophy.

Transl Neurodegener. 2022 Feb 7;11(1):7. doi: 10.1186/s40035-022-00283-4.

Phosphorylated α-synuclein and phosphorylated tau-protein in sural nerves may contribute to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear paralysis.

Neurosci Lett. 2021 Jun 21;756:135964. doi: 10.1016/j.neulet.2021.135964. Epub 2021 May 19.

Lysosomal response in relation to α-synuclein pathology differs between Parkinson's disease and multiple system atrophy.

Neurobiol Dis. 2018 Jun;114:140-152. doi: 10.1016/j.nbd.2018.02.019. Epub 2018 Mar 2.

Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy.

Neuropathol Appl Neurobiol. 2007 Dec;33(6):615-20. doi: 10.1111/j.1365-2990.2007.00907.x.

Towards translational therapies for multiple system atrophy.

Prog Neurobiol. 2014 Jul;118:19-35. doi: 10.1016/j.pneurobio.2014.02.007. Epub 2014 Mar 2.

引用本文的文献

Late-onset multiple system atrophy: Neuropathological features associated with slow disease progression.

Brain Pathol. 2025 Sep;35(5):e70016. doi: 10.1111/bpa.70016. Epub 2025 May 19.

Heterogeneity of Multiple System Atrophy: An Update.

Biomedicines. 2022 Mar 3;10(3):599. doi: 10.3390/biomedicines10030599.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Late-onset MSA differs from younger-onset MSA.

J Neurol Neurosurg Psychiatry. 2023 Jul;94(7):583. doi: 10.1136/jnnp-2022-328793. Epub 2022 Jun 2.

Alpha-synuclein in erythrocyte membrane of patients with multiple system atrophy: A pilot study.

Parkinsonism Relat Disord. 2019 Mar;60:105-110. doi: 10.1016/j.parkreldis.2018.09.012. Epub 2018 Sep 11.

Definite familial multiple system atrophy with unknown genetics.

Neuropathology. 2014 Jun;34(3):309-13. doi: 10.1111/neup.12092. Epub 2014 Jan 7.

Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy.

J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):175-184. doi: 10.1136/jnnp-2017-315813. Epub 2017 Aug 31.

Distinct Autoimmune Anti-α-Synuclein Antibody Patterns in Multiple System Atrophy and Parkinson's Disease.

Front Immunol. 2019 Sep 24;10:2253. doi: 10.3389/fimmu.2019.02253. eCollection 2019.

Alpha-synuclein seeding shows a wide heterogeneity in multiple system atrophy.

Transl Neurodegener. 2022 Feb 7;11(1):7. doi: 10.1186/s40035-022-00283-4.

Phosphorylated α-synuclein and phosphorylated tau-protein in sural nerves may contribute to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear paralysis.

Neurosci Lett. 2021 Jun 21;756:135964. doi: 10.1016/j.neulet.2021.135964. Epub 2021 May 19.

Lysosomal response in relation to α-synuclein pathology differs between Parkinson's disease and multiple system atrophy.

Neurobiol Dis. 2018 Jun;114:140-152. doi: 10.1016/j.nbd.2018.02.019. Epub 2018 Mar 2.

Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy.

Neuropathol Appl Neurobiol. 2007 Dec;33(6):615-20. doi: 10.1111/j.1365-2990.2007.00907.x.

Towards translational therapies for multiple system atrophy.

Prog Neurobiol. 2014 Jul;118:19-35. doi: 10.1016/j.pneurobio.2014.02.007. Epub 2014 Mar 2.

引用本文的文献

Late-onset multiple system atrophy: Neuropathological features associated with slow disease progression.

Brain Pathol. 2025 Sep;35(5):e70016. doi: 10.1111/bpa.70016. Epub 2025 May 19.

Heterogeneity of Multiple System Atrophy: An Update.

Biomedicines. 2022 Mar 3;10(3):599. doi: 10.3390/biomedicines10030599.